BlueCrest Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,861	Closed	-$255K	–	789
2017 Q3	$255K	Buy	+9,861	New	+$255K	0.01%	659